JILL JENSEN: Open Payments
NPI 1477652469 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 45 payments from 17 companies in 2025. Trend: 2023 $646 · 2024 $736 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Novo Nordisk Inc | 6 | $106 |
| ABBVIE INC. | 6 | $106 |
| Lilly USA, LLC | 4 | $69 |
| Abbott Laboratories | 3 | $68 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Xeris Pharmaceuticals, Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $39 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, UBRELVY, REXULTI, GEMTESA, Wegovy, Kerendia, GVOKE HYPOPEN.
Industry payments across IA — which companies pay providers there.
